Objective
Brown adipose tissue (BAT) is critical for thermogenesis and glucose/lipid homeostasis. Exploiting the energy uncoupling capacity of BAT may reveal targets for obesity therapies. This exploitation requires a greater understanding of the transcriptional mechanisms underlying BAT function. One potential regulator of BAT is the transcriptional co-regulator LIM domain-binding protein 1 (LDB1), which acts as a dimerized scaffold, allowing for the assembly of transcriptional complexes. Utilizing a global LDB1 heterozygous mouse model, we recently reported that LDB1 might have novel roles in regulating BAT function. However,
direct
evidence for the LDB1 regulation of BAT thermogenesis and substrate utilization has not been elucidated. We hypothesize that brown adipocyte-expressed LDB1 is required for BAT function.
Methods
LDB1-deficient primary cells and brown adipocyte cell lines were assessed via qRT-PCR and western blotting for altered mRNA and protein levels to define the brown adipose-specific roles. We conducted chromatin immunoprecipitation with primary BAT tissue and immortalized cell lines. Potential transcriptional partners of LDB1 were revealed by conducting LIM factor surveys via qRT-PCR in mouse and human brown adipocytes. We developed a
Ucp1
-Cre-driven LDB1-deficiency mouse model, termed
Ldb1
ΔBAT
, to test LDB1 function
in vivo
. Glucose tolerance and uptake were assessed at thermoneutrality via intraperitoneal glucose challenge and glucose tracer studies. Insulin tolerance was measured at thermoneutrality and after stimulation with cold or the administration of the β3-adrenergic receptor (β3-AR) agonist CL316,243. Additionally, we analyzed plasma insulin via ELISA and insulin signaling via western blotting. Lipid metabolism was evaluated via BAT weight, histology, lipid droplet morphometry, and the examination of lipid-associated mRNA. Finally, energy expenditure and cold tolerance were evaluated via indirect calorimetry and cold challenges.
Results
Reducing
Ldb1 in vitro
and
in vivo
resulted in altered BAT-selective mRNA, including
Ucp1
,
Elovl3
, and
Dio2
. In addition, there was reduced
Ucp1
induction
in vitro
. Impacts on gene expression may be due, in part, to LDB1 occupying
Ucp1
upstream regulatory domains. We also identified BAT-expressed LIM-domain factors
Lmo2
,
Lmo4
, and
Lhx8
, which may partner with LDB1 to mediate activity in brown adipocytes. Additionally, we observed
LDB1
enrichment in human brown adipose.
In vivo
analysis revealed LDB1 i...